Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zia-Amirhosseini

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Toxicologic Pathology|March 1, 1995
Basic principles of pharmacokineticsL Z Benet, P Zia-Amirhosseini
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Bioactivation by glucuronide-conjugate formationP Zia-Amirhosseini, H Spahn-Langguth, L Z Benet
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1995
Stereoselective reversible binding properties of the glucuronide conjugates of fenoprofen enantiomers to human serum albuminA Bischer, M Iwaki, P Zia-Amirhosseini, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1995
Stereoselective binding properties of naproxen glucuronide diastereomers to proteinsA Bischer, P Zia-Amirhosseini, M Iwaki, et al.
The Biochemical Journal|October 15, 1995
Synthesis and mass-spectrometric characterization of human serum albumins modified by covalent binding of two non-steroidal anti-inflammatory drugs: tolmetin and zomepiracP Zia-Amirhosseini, A Ding, A L Burlingame, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1995
Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometryA Ding, P Zia-Amirhosseini, A F McDonagh, et al.
Clinical Pharmacology and Therapeutics|January 1, 1994
Enhanced covalent binding of tolmetin to proteins in humans after multiple dosingP Zia-Amirhosseini, J C Ojingwa, H Spahn-Langguth, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeysP Zia-Amirhosseini, E Minthorn, L J Benincosa, et al.
Journal of Clinical Pharmacology|November 15, 2006
Effect of renal function on the pharmacokinetics of paliferminB Gillespie, P Zia-Amirhosseini, M Salfi, et al.
Clinical and Experimental Immunology|September 26, 2002
Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthmaT K Hart, M N Blackburn, M Brigham-Burke, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Toxicologic Pathology|March 1, 1995
Basic principles of pharmacokineticsL Z Benet, P Zia-Amirhosseini
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Bioactivation by glucuronide-conjugate formationP Zia-Amirhosseini, H Spahn-Langguth, L Z Benet
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1995
Stereoselective reversible binding properties of the glucuronide conjugates of fenoprofen enantiomers to human serum albuminA Bischer, M Iwaki, P Zia-Amirhosseini, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1995
Stereoselective binding properties of naproxen glucuronide diastereomers to proteinsA Bischer, P Zia-Amirhosseini, M Iwaki, et al.
The Biochemical Journal|October 15, 1995
Synthesis and mass-spectrometric characterization of human serum albumins modified by covalent binding of two non-steroidal anti-inflammatory drugs: tolmetin and zomepiracP Zia-Amirhosseini, A Ding, A L Burlingame, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1995
Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometryA Ding, P Zia-Amirhosseini, A F McDonagh, et al.
Clinical Pharmacology and Therapeutics|January 1, 1994
Enhanced covalent binding of tolmetin to proteins in humans after multiple dosingP Zia-Amirhosseini, J C Ojingwa, H Spahn-Langguth, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeysP Zia-Amirhosseini, E Minthorn, L J Benincosa, et al.
Journal of Clinical Pharmacology|November 15, 2006
Effect of renal function on the pharmacokinetics of paliferminB Gillespie, P Zia-Amirhosseini, M Salfi, et al.
Clinical and Experimental Immunology|September 26, 2002
Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthmaT K Hart, M N Blackburn, M Brigham-Burke, et al.
Pageof 2